Benitec Biopharma Inc (BNTC)
9.23
+0.44
(+5.01%)
USD |
NASDAQ |
Sep 27, 16:00
9.025
-0.20
(-2.22%)
After-Hours: 20:00
Benitec Biopharma Cash from Operations (Quarterly): -3.293M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -3.293M |
| March 31, 2024 | -6.168M |
| December 31, 2023 | -5.365M |
| September 30, 2023 | -4.577M |
| June 30, 2023 | -4.095M |
| March 31, 2023 | -4.029M |
| December 31, 2022 | -5.843M |
| September 30, 2022 | -4.045M |
| June 30, 2022 | -4.855M |
| March 31, 2022 | -3.422M |
| Date | Value |
|---|---|
| December 31, 2021 | -3.344M |
| September 30, 2021 | -4.278M |
| June 30, 2021 | -5.157M |
| March 31, 2021 | -1.989M |
| December 31, 2020 | -3.326M |
| September 30, 2020 | -2.36M |
| June 30, 2020 | -3.145M |
| March 31, 2020 | -0.769M |
| December 31, 2019 | -3.076M |
| September 30, 2019 | -0.545M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-6.168M
Minimum
Mar 2024
-0.545M
Maximum
Sep 2019
-3.684M
Average
-3.726M
Median
Cash from Operations (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.578M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -4.854M |
| Theriva Biologics Inc | -3.452M |
| Oragenics Inc | -1.544M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 40.07M |
| Free Cash Flow | -19.58M |
| Free Cash Flow Per Share (Quarterly) | -0.3265 |
| Free Cash Flow Yield | -48.67% |